Healthcare sector | Medical Devices industry
| Price | $10.66 |
|---|---|
| Shares Outstanding | 41.92M |
| All-Time Low | $6.76 |
| 52-Week Low | $6.76 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $0.63 |
| Net Tangible Assets / Share | $6.62 |
| Shares Outstanding Ave Change (Annual) | 1.32% |
| Shares Δ YoY | 1.45% |
| Avg CA Burn (Annual %) | 1.80% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | -0.75% (as of 2-20-2026) |
| Max Earning Power / Share | $4.09 |
|---|---|
| Adjusted Earning Power |
$0.52
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.52%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 67.3M (as of 2-20-2026) |
| Avg EBITDA (5Q) | 18M (as of 2-20-2026) |
| Avg Net Income (5Y) | -10.3M (as of 2-20-2026) |
| Avg Net Income (5Q) | -13.6M (as of 2-20-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 2-20-2026 |
| Net Income Positive | Yes | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $6.29 | 263.8M ($263,800,000) | 41.9M (41,919,432) |
| 2025-09-30 | Quarterly | $6.24 | 260.2M ($260,200,000) | 41.7M (41,689,672) |
| 2025-09-30 | Annual | $6.24 | 260.2M ($260,200,000) | 41.7M (41,689,672) |
| 2025-06-30 | Quarterly | $5.82 | 241.8M ($241,800,000) | 41.5M (41,520,742) |
| 2025-03-31 | Quarterly | $5.88 | 244.1M ($244,100,000) | 41.5M (41,512,831) |
| 2024-12-31 | Quarterly | $5.79 | 238.8M ($238,800,000) | 41.2M (41,231,000) |
| 2024-09-30 | Annual | $5.40 | 222M ($222,000,000) | 41.1M (41,094,179) |
| 2023-09-30 | Annual | $6.34 | 256.8M ($256,800,000) | 40.5M (40,529,573) |
| 2022-09-30 | Annual | $5.37 | 215.3M ($215,300,000) | 40.1M (40,085,126) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2025-09-30 | 844.6M ($844,600,000) |
| 2024-09-30 | 811M ($811,000,000) |
| 2023-09-30 | 893.4M ($893,400,000) |
| 2022-09-30 | 859.4M ($859,400,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-01-05 | 41,919,432 | +229,760 |
| 2025-11-20 | 41,689,672 | +168,930 |
| 2025-09-17 | 41,520,742 | +42 |
| 2025-08-12 | 41,520,700 | +7,900 |
Latest short-interest change: 1,176,799 shares (3.17% of float) | Days to cover: 3.03
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 1,176,799 shares | -67,118 | -5.40% |
| 2026-02-27 | 1,243,917 shares | +431,484 | +53.11% |
| 2026-02-11 | 812,433 shares | -67,654 | -7.69% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.